Despite the failure of HealthSpot, Xerox, a key investor in that company, still wants to be a major player in telehealth.
Xerox invested an undisclosed sum in Dublin, Ohio-based HealthSpot in November 2014. At the time, HealthSpot CEO Steve Cashman called Xerox the company’s largest business partner.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
(CrunchBase, which tracks venture capital, noted that HealthSpot received two rounds of debt financing in November 2014, worth a total of $9.14 million, but did not specify the source.)
Xerox, of Norwalk, Connecticut, did not initially respond Wednesday to an inquiry from MedCity News, but an outside marketing agency saw our coverage and send this statement from Xerox Commercial Healthcare’s Chief Innovation Officer Tamara StClaire:
We are disappointed to hear HealthSpot’s news. However, the health IT solution and services that Xerox built to power the HealthSpot kiosk can be leveraged for other telehealth platforms. We remain committed to supplying a suite of telehealth services powered by Xerox infrastructure to the industry and will continue to work with startups and small companies to openly innovate and collaborate on new ideas for products and services that benefit consumers and deliver on our vision of anywhere care.
HealthSpot itself still has not answered media queries.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
